Katie Curran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Katie Curran has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Tunde Peto
Centre for Public Health, Queen’s University Belfast, Belfast, UK
15 shared publications - Laura Nicole Cushley
Centre for Public Health, Queen’s University Belfast, Belfast, UK
8 shared publications Nathan Congdon
Faculty of Medicine Health and Life Sciences, Queen’s University Belfast, Great Britain and Northern Ireland, Belfast, UK
7 shared publicationsTunde Peto
5 shared publicationsCatherine Dardis
Department of Ophthalmology, Belfast Health and Social Care Trust, Belfast, UK
3 shared publications- Giuliana Silvestri
Department of Ophthalmology, Belfast Health and Social Care Trust, Belfast, UK
3 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by Springer Nature in Ophthalmic and Physiological Optics
- Vol. 46 (6) , 1289-1295
The Diabetes Complications in Senior Adults (DCSA) Study: A Scoping Review and a National Case Analysis from Northern Ireland, UK on Ocular Complications in Adults Aged 80 and over Living with Diabetes
Background: The number of people 80 years and over with a diagnosis of diabetes is increasing. This is due to people with type 1 diabetes living longer, successful diabetes management and a growing aging population. Due to this increase, there is limited understanding of the impact of diabetes in people 80 years or over, especially in relation to diabetic retinal disease (DRD) and other ocular complications. Methodology: A scoping review was conducted using PRISMA-ScR guidelines, with two reviewers independently screening abstracts and full texts. Case study data were obtained from the Northern Ireland Diabetic Eye Screening Programme. Results and Summary: Database searches identified 1644 references, of which seven studies met the inclusion criteria following review. Across these, 29,734 participants were included, with 14,920 (50%) aged 80 years and over. The reported prevalence of diabetic retinopathy (DR) and diabetic maculopathy (DM) varied considerably across studies, ranging from 0.8% in Australia to 9.5% and 11.6% in Thailand and Suriname, respectively. This substantial variation may be attributable to differences in participant characteristics, study populations, geographical and regional settings, diagnostic and grading criteria for DR and DM and other methodological factors. Some studies reported the incidence of DRD in people 80 years and over was higher in those with a longer duration of diabetes. However, none have provided a comprehensive understanding of the burden of both diabetes-related and other ocular diseases within this older patient cohort. This case study found that approximately 20% of individuals aged 80 years and over had a diagnosis of diabetes. Although the proportion with proliferative, sight-threatening diabetic retinopathy was small (0.6%), this rate is comparable to the general population of people with diabetes. Conclusion: Few studies have examined DRD in people 80 years and over. This case study aligns with the limited available evidence and highlights the continued importance of screening in this population.
- 29 September 2026
- Published by Springer Nature in Ophthalmic and Physiological Optics
- Vol. 46 (6) , 1289-1295
Open AccessThe Diabetes Complications in Senior Adults (DCSA) Study: A Scoping Review and a National Case Analysis from Northern Ireland, UK on Ocular Complications in Adults Aged 80 and over Living with Diabetes
Background: The number of people 80 years and over with a diagnosis of diabetes is increasing. This is due to people with type 1 diabetes living longer, successful diabetes management and a growing aging population. Due to this increase, there is limited understanding of the impact of diabetes in people 80 years or over, especially in relation to diabetic retinal disease (DRD) and other ocular complications. Methodology: A scoping review was conducted using PRISMA-ScR guidelines, with two reviewers independently screening abstracts and full texts. Case study data were obtained from the Northern Ireland Diabetic Eye Screening Programme. Results and Summary: Database searches identified 1644 references, of which seven studies met the inclusion criteria following review. Across these, 29,734 participants were included, with 14,920 (50%) aged 80 years and over. The reported prevalence of diabetic retinopathy (DR) and diabetic maculopathy (DM) varied considerably across studies, ranging from 0.8% in Australia to 9.5% and 11.6% in Thailand and Suriname, respectively. This substantial variation may be attributable to differences in participant characteristics, study populations, geographical and regional settings, diagnostic and grading criteria for DR and DM and other methodological factors. Some studies reported the incidence of DRD in people 80 years and over was higher in those with a longer duration of diabetes. However, none have provided a comprehensive understanding of the burden of both diabetes-related and other ocular diseases within this older patient cohort. This case study found that approximately 20% of individuals aged 80 years and over had a diagnosis of diabetes. Although the proportion with proliferative, sight-threatening diabetic retinopathy was small (0.6%), this rate is comparable to the general population of people with diabetes. Conclusion: Few studies have examined DRD in people 80 years and over. This case study aligns with the limited available evidence and highlights the continued importance of screening in this population.
- Open Access
- 26 February 2026
- Published by SAGE Publications in British Journal of Visual Impairment
Accessibility for the visually impaired community in hospitality and tourism: A scoping review
People with visual impairment are faced with daily accessibility challenges, including accessing hospitality and tourism venues. This scoping review aims to assess existing literature in hospitality and tourism for people with visual impairment. Two databases, Scopus and Web of Science, were searched using keywords and Boolean operators. Covidence was used for screening and data extraction by two reviewers. A total of 23 articles were included from 2003 to 2024, with a majority (91%) of studies conducted in high-income countries. Many (69.7%) focussed solely on tourism, only one was conducted solely on hospitality, and the others were a combination. Some of the biggest concerns identified were physical inaccessibility barriers, negative societal attitudes, lack of training and awareness of staff, and inaccessible signage/information. In conclusion, there is existing literature on barriers and enablers of travel for people with visual impairment but limited research on hospitality and potential solutions.
- 26 February 2026
- Published by SAGE Publications in British Journal of Visual Impairment
Open AccessAccessibility for the visually impaired community in hospitality and tourism: A scoping review
People with visual impairment are faced with daily accessibility challenges, including accessing hospitality and tourism venues. This scoping review aims to assess existing literature in hospitality and tourism for people with visual impairment. Two databases, Scopus and Web of Science, were searched using keywords and Boolean operators. Covidence was used for screening and data extraction by two reviewers. A total of 23 articles were included from 2003 to 2024, with a majority (91%) of studies conducted in high-income countries. Many (69.7%) focussed solely on tourism, only one was conducted solely on hospitality, and the others were a combination. Some of the biggest concerns identified were physical inaccessibility barriers, negative societal attitudes, lack of training and awareness of staff, and inaccessible signage/information. In conclusion, there is existing literature on barriers and enablers of travel for people with visual impairment but limited research on hospitality and potential solutions.
- Open Access
Sleep improvement strategies for people with vision impairment: a scoping review
Objectives: To explore existing strategies for managing sleep disorders in individuals with vision impairment (VI), identifying interventions, geographical trends and research gaps. Design: Scoping review. Data sources: Medline ALL (Ovid), Embase and Web of Science Core Collection, with supplementary searches in Google Scholar. The final search was completed on 28 November 2025. Eligibility criteria for selecting studies: Original research studies examining strategies to manage sleep disorders in adults (≥18 years) with VI, published in English. Studies focusing on animal models or unrelated to sleep management were excluded. Data extraction and synthesis: Two reviewers independently screened titles, abstracts and full texts using Covidence, extracted data using a predefined form and resolved discrepancies by consensus. A narrative synthesis approach was used to summarise findings by intervention type, study design and outcomes. Results: Of 4368 records screened, 16 studies met inclusion criteria. Participants ranged from 18 years to 85 years (median 40.5). Most studies included individuals with no light perception, though VI definitions were often inconsistent. Pharmacological interventions dominated (13/16, 81.3%), mainly melatonin or melatonin receptor agonists, with some use of zopiclone, low-dose benzodiazepines and tricyclic antidepressants. Non-pharmacological approaches were under-represented, including bright light exposure (n=1), virtual Hatha yoga (n=1) and caffeine modulation (n=1). Substantial variation existed in sleep assessment methods. Conclusions: This scoping review highlights the predominant focus on pharmacological treatments, especially melatonin, while non-pharmacological strategies remain underexplored. Future research should explore accessible, non-pharmacological interventions and address sleep health inequities faced by individuals with VI. Registration: 10.17605/OSF.IO/7E83R.
Open AccessSleep improvement strategies for people with vision impairment: a scoping review
Objectives: To explore existing strategies for managing sleep disorders in individuals with vision impairment (VI), identifying interventions, geographical trends and research gaps. Design: Scoping review. Data sources: Medline ALL (Ovid), Embase and Web of Science Core Collection, with supplementary searches in Google Scholar. The final search was completed on 28 November 2025. Eligibility criteria for selecting studies: Original research studies examining strategies to manage sleep disorders in adults (≥18 years) with VI, published in English. Studies focusing on animal models or unrelated to sleep management were excluded. Data extraction and synthesis: Two reviewers independently screened titles, abstracts and full texts using Covidence, extracted data using a predefined form and resolved discrepancies by consensus. A narrative synthesis approach was used to summarise findings by intervention type, study design and outcomes. Results: Of 4368 records screened, 16 studies met inclusion criteria. Participants ranged from 18 years to 85 years (median 40.5). Most studies included individuals with no light perception, though VI definitions were often inconsistent. Pharmacological interventions dominated (13/16, 81.3%), mainly melatonin or melatonin receptor agonists, with some use of zopiclone, low-dose benzodiazepines and tricyclic antidepressants. Non-pharmacological approaches were under-represented, including bright light exposure (n=1), virtual Hatha yoga (n=1) and caffeine modulation (n=1). Substantial variation existed in sleep assessment methods. Conclusions: This scoping review highlights the predominant focus on pharmacological treatments, especially melatonin, while non-pharmacological strategies remain underexplored. Future research should explore accessible, non-pharmacological interventions and address sleep health inequities faced by individuals with VI. Registration: 10.17605/OSF.IO/7E83R.
- Open Access
Exploring Sleep Challenges and Interventions in Children with a Vision Impairment: A Scoping Review
Background/Objectives: Sleep problems are highly prevalent among children with vision impairment and can negatively affect physical, emotional, and cognitive development. There is a need to identify and evaluate effective interventions in this population. This scoping review aimed to map the range of sleep challenges experienced by these children and to summarise the interventions evaluated to date. Methods: Systematic searches were performed in Embase, Medline, and Web of Science Core Collection. Screening was completed in Covidence, and data extraction and descriptive analysis were conducted using Microsoft Excel (version 2510) and IBM SPSS Statistics (version 30). Narrative synthesis was used to summarise findings. Results: Fifteen studies were included, over half of which were case reports. The vast majority (14/15) were conducted in high-income countries, leaving a significant evidence gap for low- and middle-income settings. Reported sleep challenges included delayed sleep onset, non-24-h sleep–wake disorder, early morning waking, and fragmented sleep. Interventions were predominantly pharmacological (11/15), with melatonin the most frequently evaluated. Across studies, melatonin demonstrated short-term effectiveness in improving sleep latency, duration, and parent-reported quality, though prescribing practices, dosages, and availability varied. Other pharmacological options, such as tasimelteon and vitamin B12, were rarely reported. Non-pharmacological strategies were evaluated in only a small number of studies and included behavioural interventions, structured routines, and activity-based therapies. These showed potential benefit but remain under-researched. Conclusions: Overall, the evidence base is small, heterogeneous, and methodologically limited. Further research is needed to develop and carefully test non-pharmacological approaches, and to compare them directly with pharmacological treatments, to provide families and clinicians with effective and sustainable options.
Open AccessExploring Sleep Challenges and Interventions in Children with a Vision Impairment: A Scoping Review
Background/Objectives: Sleep problems are highly prevalent among children with vision impairment and can negatively affect physical, emotional, and cognitive development. There is a need to identify and evaluate effective interventions in this population. This scoping review aimed to map the range of sleep challenges experienced by these children and to summarise the interventions evaluated to date. Methods: Systematic searches were performed in Embase, Medline, and Web of Science Core Collection. Screening was completed in Covidence, and data extraction and descriptive analysis were conducted using Microsoft Excel (version 2510) and IBM SPSS Statistics (version 30). Narrative synthesis was used to summarise findings. Results: Fifteen studies were included, over half of which were case reports. The vast majority (14/15) were conducted in high-income countries, leaving a significant evidence gap for low- and middle-income settings. Reported sleep challenges included delayed sleep onset, non-24-h sleep–wake disorder, early morning waking, and fragmented sleep. Interventions were predominantly pharmacological (11/15), with melatonin the most frequently evaluated. Across studies, melatonin demonstrated short-term effectiveness in improving sleep latency, duration, and parent-reported quality, though prescribing practices, dosages, and availability varied. Other pharmacological options, such as tasimelteon and vitamin B12, were rarely reported. Non-pharmacological strategies were evaluated in only a small number of studies and included behavioural interventions, structured routines, and activity-based therapies. These showed potential benefit but remain under-researched. Conclusions: Overall, the evidence base is small, heterogeneous, and methodologically limited. Further research is needed to develop and carefully test non-pharmacological approaches, and to compare them directly with pharmacological treatments, to provide families and clinicians with effective and sustainable options.
- Open Access
- 1 December 2025
- Published by MDPI AG in Diabetology
- Vol. 6 (12) , 152
Complications and Comorbidities in Individuals >80 Years with Diabetes: A Scoping Review
Background/Objectives: Diabetes mellitus is increasingly prevalent among adults aged over 80 years; however, this population remains substantially underrepresented in clinical research on diabetes complications. This scoping review synthesises current evidence on diabetes-related complications and comorbidities in this older age group (>80 years), reported prevalence, and key evidence gaps. Methods: A systematic search of MEDLINE, Embase, and Web of Science was conducted for studies published between 1992 and 2024 reporting diabetes-related complications in individuals aged ≥80 years. Two reviewers independently screened titles, abstracts, and full texts. Data were extracted and summarised using narrative synthesis, and descriptive statistics (SPSS v29) were conducted. Results: Fifty-one studies were included, comprising 17,630,083 individuals aged ≥80 years. Macrovascular complications were most frequently reported, followed by microvascular and peripheral outcomes. Hypertension was the most reported comorbidity. Macrovascular outcomes were assessed in over 17 million individuals, while microvascular complications were studied in fewer than 400,000. Only five studies focused exclusively on adults aged ≥80 years. Reporting was also limited by retrospective designs, heterogeneity in definitions, and frequent omission of key variables, including diabetes duration, HbA1c, frailty, and cognitive status. Conclusions: There is a critical mismatch between research focus and the complications most relevant to function and quality of life in older populations with diabetes. Easily measurable yet clinically impactful outcomes, such as retinopathy, neuropathy, nephropathy, and foot disease, remain under-investigated in this cohort. Standardised, age-stratified reporting that incorporates functional and geriatric domains is needed to inform person-centred care in this expanding population.
- 1 December 2025
- Published by MDPI AG in Diabetology
- Vol. 6 (12) , 152
Open AccessComplications and Comorbidities in Individuals >80 Years with Diabetes: A Scoping Review
Background/Objectives: Diabetes mellitus is increasingly prevalent among adults aged over 80 years; however, this population remains substantially underrepresented in clinical research on diabetes complications. This scoping review synthesises current evidence on diabetes-related complications and comorbidities in this older age group (>80 years), reported prevalence, and key evidence gaps. Methods: A systematic search of MEDLINE, Embase, and Web of Science was conducted for studies published between 1992 and 2024 reporting diabetes-related complications in individuals aged ≥80 years. Two reviewers independently screened titles, abstracts, and full texts. Data were extracted and summarised using narrative synthesis, and descriptive statistics (SPSS v29) were conducted. Results: Fifty-one studies were included, comprising 17,630,083 individuals aged ≥80 years. Macrovascular complications were most frequently reported, followed by microvascular and peripheral outcomes. Hypertension was the most reported comorbidity. Macrovascular outcomes were assessed in over 17 million individuals, while microvascular complications were studied in fewer than 400,000. Only five studies focused exclusively on adults aged ≥80 years. Reporting was also limited by retrospective designs, heterogeneity in definitions, and frequent omission of key variables, including diabetes duration, HbA1c, frailty, and cognitive status. Conclusions: There is a critical mismatch between research focus and the complications most relevant to function and quality of life in older populations with diabetes. Easily measurable yet clinically impactful outcomes, such as retinopathy, neuropathy, nephropathy, and foot disease, remain under-investigated in this cohort. Standardised, age-stratified reporting that incorporates functional and geriatric domains is needed to inform person-centred care in this expanding population.
- Open Access
- 15 October 2025
- Published by Springer Nature in Eye Open
- Vol. 1 (1) , 1-5
Exploring sleep and vision impairment through a Patient and Public Involvement and Engagement (PPIE) lens: insights from multiple stakeholders
- 15 October 2025
- Published by Springer Nature in Eye Open
- Vol. 1 (1) , 1-5
Open AccessExploring sleep and vision impairment through a Patient and Public Involvement and Engagement (PPIE) lens: insights from multiple stakeholders
- Open Access
The Retinal Complications of C3 Dense Deposit Disease: A Scoping Review
People with C3 Dense Deposit Disease (C3DDD), a rare autoimmune disease, often also have ocular complications. Due to the rarity of this disease, there is little known about ocular complications in populations across the world. This paper aimed to assess literature on retinal complications in people with C3 Dense Deposit Disease. A scoping review was conducted and three databases (Embase, Medline All, and Web of Science) were searched using agreed search terms and Boolean operators. All references were imported into Covidence for screening by two reviewers. Any conflicts were resolved by a third reviewer. Data were extracted into an Excel spreadsheet and analysis was conducted using SPSS Version 29. After full text screening, 38 studies were included in the review. These studies were from 1990–2023 and most (67%) being case reports. All studies were conducted in the United States (55%) or Europe (45%). Most studies reported drusen-like deposits in the retina (75%) and retinal pigment epithelial detachment (18%) and macular atrophy (11%). Choroidal Neovascularisation (CNV) was found in 16% of cases. People with C3 Dense Deposit Disease are at risk of ocular complications, primarily drusen-like deposits. Further population-based research and progression is needed.
Open AccessThe Retinal Complications of C3 Dense Deposit Disease: A Scoping Review
People with C3 Dense Deposit Disease (C3DDD), a rare autoimmune disease, often also have ocular complications. Due to the rarity of this disease, there is little known about ocular complications in populations across the world. This paper aimed to assess literature on retinal complications in people with C3 Dense Deposit Disease. A scoping review was conducted and three databases (Embase, Medline All, and Web of Science) were searched using agreed search terms and Boolean operators. All references were imported into Covidence for screening by two reviewers. Any conflicts were resolved by a third reviewer. Data were extracted into an Excel spreadsheet and analysis was conducted using SPSS Version 29. After full text screening, 38 studies were included in the review. These studies were from 1990–2023 and most (67%) being case reports. All studies were conducted in the United States (55%) or Europe (45%). Most studies reported drusen-like deposits in the retina (75%) and retinal pigment epithelial detachment (18%) and macular atrophy (11%). Choroidal Neovascularisation (CNV) was found in 16% of cases. People with C3 Dense Deposit Disease are at risk of ocular complications, primarily drusen-like deposits. Further population-based research and progression is needed.
- Open Access
- 13 January 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (1) , 99
Visual Acuity Outcomes and Influencing Factors in a Cohort of UK Real-World Diabetic Macular Oedema Patients During the First Two Years of Anti-VEGF Treatment
Background/Objectives: The visual acuity (VA) outcomes after the first and second years of anti-vascular endothelial growth factor (anti-VEGF) treatment in patients with diabetic macular oedema (DMO) were evaluated, and the factors associated with treatment success were investigated. Methods: Using Medisoft electronic medical records (UK), this retrospective cohort study analysed VA outcomes, changes, and determinants in DMO patients at year 1 and year 2 after initial anti-VEGF injection. Descriptive analysis examined baseline demographics and clinical characteristics, while regression models were used to assess associations between these factors and changes in VA. Results: 728 DMO patients (1035 eyes) treated with anti-VEGFs (ranibizumab, aflibercept, or bevacizumab) at the Northern Ireland Mater Macular Clinic from 2008 to 2021 were evaluated. The mean age was 64.5 (SD 12.8) years, and 59.6% were male. In the first year, the median annual injection number and interval were 6.0 (IQR 5.0–8.0) and 6.1 weeks (IQR 5.4–7.8), respectively, and in the second year, they were 3.0 (IQR 2.0–5.0) and 10.0 weeks (IQR 6.5–20.1). In the first two treatment years, 83.4% and 79.8% of eyes had improved/stable VA (ISVA) respectively. The injection number, interval, baseline VA, age, and proliferative diabetic retinopathy (PDR) significantly impacted VA outcomes. Conclusions: Our study confirms the effectiveness of anti-VEGF treatments in improving or maintaining vision for DMO patients, consistent with previous real-world clinical data. An elder age, a better baseline VA, low annual injection numbers (<5), and less frequent injection intervals (≥12 weeks) were negatively associated with ISVA success in the first two years. These findings have implications for managing patient expectations, allocating resources, and understanding DMO clinical management.
- 13 January 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (1) , 99
Open AccessVisual Acuity Outcomes and Influencing Factors in a Cohort of UK Real-World Diabetic Macular Oedema Patients During the First Two Years of Anti-VEGF Treatment
Background/Objectives: The visual acuity (VA) outcomes after the first and second years of anti-vascular endothelial growth factor (anti-VEGF) treatment in patients with diabetic macular oedema (DMO) were evaluated, and the factors associated with treatment success were investigated. Methods: Using Medisoft electronic medical records (UK), this retrospective cohort study analysed VA outcomes, changes, and determinants in DMO patients at year 1 and year 2 after initial anti-VEGF injection. Descriptive analysis examined baseline demographics and clinical characteristics, while regression models were used to assess associations between these factors and changes in VA. Results: 728 DMO patients (1035 eyes) treated with anti-VEGFs (ranibizumab, aflibercept, or bevacizumab) at the Northern Ireland Mater Macular Clinic from 2008 to 2021 were evaluated. The mean age was 64.5 (SD 12.8) years, and 59.6% were male. In the first year, the median annual injection number and interval were 6.0 (IQR 5.0–8.0) and 6.1 weeks (IQR 5.4–7.8), respectively, and in the second year, they were 3.0 (IQR 2.0–5.0) and 10.0 weeks (IQR 6.5–20.1). In the first two treatment years, 83.4% and 79.8% of eyes had improved/stable VA (ISVA) respectively. The injection number, interval, baseline VA, age, and proliferative diabetic retinopathy (PDR) significantly impacted VA outcomes. Conclusions: Our study confirms the effectiveness of anti-VEGF treatments in improving or maintaining vision for DMO patients, consistent with previous real-world clinical data. An elder age, a better baseline VA, low annual injection numbers (<5), and less frequent injection intervals (≥12 weeks) were negatively associated with ISVA success in the first two years. These findings have implications for managing patient expectations, allocating resources, and understanding DMO clinical management.
- Open Access
- 4 December 2024
- Published by Springer Nature in Clinical Diabetes and Endocrinology
- Vol. 10 (1) , 1-11
Adherence to diabetic retinopathy screening among children and young adults in Bangladesh
Background: Effective diabetic retinopathy screening (DRS) programmes are important in preventing vision impairment and blindness caused by diabetes. This study focuses on identifying the factors affecting attendance or non-adherence to DRS among children and young adults with diabetes mellitus (DM) in Bangladesh. Methods: A mixed-methods approach was used, which included patients diagnosed with DM aged 12–26 years from Bangladesh who were registered at BIRDEM Women and Children hospital in Dhaka. Data collection occurred between July 2019 and July 2020, mainly through telephone and email due to restrictions imposed by the COVID-19 pandemic. Statistical analyses, including chi-squared tests, t-tests, and logistic regression, were used to assess the demographic and clinical factors influencing attendance at DRS. Results: The study reported a high 88% attendance rate for DRS among children and young adults in Bangladesh. However, some barriers to attendance were identified. Children under 15 years of age showed a higher tendency to attend their last DRS appointment when compared to older age participants (16–26 years), P < 0.05. Male participants demonstrated a lower likelihood of attending their DRS appointments than females (OR 0.29, CI: 0.17 to 0.50), P < 0.001. Additionally, participants with higher HbA1c levels (mean 9.1%, IQR 2.5) attended their last DRS appointment compared to those with lower levels (mean 8.0%) (p < 0.05). The primary barriers leading to missed DRS appointments were distance to the hospital (15, 31.9%), financial limitations (19, 40.4%), and busy schedules (14, 29.8%). Conclusions: Compliance with DRS was high in this setting especially among younger patients, females, and those with higher HbA1c levels, highlighting the effectiveness of current DRS initiatives in Bangladesh. Addressing barriers such as cost, service accessibility and transportation could improve attendance rates further, and strategies such as flexible scheduling, transport subsidies, telemedicine, and use of artificial intelligence may help overcome these challenges.
- 4 December 2024
- Published by Springer Nature in Clinical Diabetes and Endocrinology
- Vol. 10 (1) , 1-11
Open AccessAdherence to diabetic retinopathy screening among children and young adults in Bangladesh
Background: Effective diabetic retinopathy screening (DRS) programmes are important in preventing vision impairment and blindness caused by diabetes. This study focuses on identifying the factors affecting attendance or non-adherence to DRS among children and young adults with diabetes mellitus (DM) in Bangladesh. Methods: A mixed-methods approach was used, which included patients diagnosed with DM aged 12–26 years from Bangladesh who were registered at BIRDEM Women and Children hospital in Dhaka. Data collection occurred between July 2019 and July 2020, mainly through telephone and email due to restrictions imposed by the COVID-19 pandemic. Statistical analyses, including chi-squared tests, t-tests, and logistic regression, were used to assess the demographic and clinical factors influencing attendance at DRS. Results: The study reported a high 88% attendance rate for DRS among children and young adults in Bangladesh. However, some barriers to attendance were identified. Children under 15 years of age showed a higher tendency to attend their last DRS appointment when compared to older age participants (16–26 years), P < 0.05. Male participants demonstrated a lower likelihood of attending their DRS appointments than females (OR 0.29, CI: 0.17 to 0.50), P < 0.001. Additionally, participants with higher HbA1c levels (mean 9.1%, IQR 2.5) attended their last DRS appointment compared to those with lower levels (mean 8.0%) (p < 0.05). The primary barriers leading to missed DRS appointments were distance to the hospital (15, 31.9%), financial limitations (19, 40.4%), and busy schedules (14, 29.8%). Conclusions: Compliance with DRS was high in this setting especially among younger patients, females, and those with higher HbA1c levels, highlighting the effectiveness of current DRS initiatives in Bangladesh. Addressing barriers such as cost, service accessibility and transportation could improve attendance rates further, and strategies such as flexible scheduling, transport subsidies, telemedicine, and use of artificial intelligence may help overcome these challenges.